NEW YORK, April 17, 2024 — The board of directors of Royalty Pharma plc has approved the payment of a dividend for the second quarter of 2024 of $0.21 per Class A ordinary share.
The dividend will be paid on June 14, 2024, to shareholders of record at the close of business on May 17, 2024.Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: